Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study

Background: Evidence suggest that diabetes and glycated hemoglobin (HbA1c) levels are associated with cancer risk. However, previous studies have been limited variably by failure to adjust for cancer-specific risk factors (e.g., body mass index), inattention to diabetes duration and use of antidiabetic medications, and failure to stratify by obesity. Methods: We examined the association between diabetes, HbA1c, and cancer risk in the UK Biobank,...